BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 22343828)

  • 1. Regulation of NF-κB signaling by the A20 deubiquitinase.
    Shembade N; Harhaj EW
    Cell Mol Immunol; 2012 Mar; 9(2):123-30. PubMed ID: 22343828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
    Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
    Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation.
    Tokunaga F; Nishimasu H; Ishitani R; Goto E; Noguchi T; Mio K; Kamei K; Ma A; Iwai K; Nureki O
    EMBO J; 2012 Oct; 31(19):3856-70. PubMed ID: 23032187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of the A20/ABIN-mediated inhibition of NF-κB signaling via modifying the ubiquitinated proteins in a basal chordate.
    Yuan S; Dong X; Tao X; Xu L; Ruan J; Peng J; Xu A
    Proc Natl Acad Sci U S A; 2014 May; 111(18):6720-5. PubMed ID: 24753567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinase IKKα inhibits activation of the transcription factor NF-κB by phosphorylating the regulatory molecule TAX1BP1.
    Shembade N; Pujari R; Harhaj NS; Abbott DW; Harhaj EW
    Nat Immunol; 2011 Jul; 12(9):834-43. PubMed ID: 21765415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of NF-κB by deubiquitinases.
    Harhaj EW; Dixit VM
    Immunol Rev; 2012 Mar; 246(1):107-24. PubMed ID: 22435550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune regulation role of A20 and its clinical significance].
    Li YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):851-6. PubMed ID: 21867600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A20: central gatekeeper in inflammation and immunity.
    Coornaert B; Carpentier I; Beyaert R
    J Biol Chem; 2009 Mar; 284(13):8217-21. PubMed ID: 19008218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
    Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
    J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating dynamic protein-protein interactions and ubiquitination in NF-κB signaling pathways.
    Shembade N; Harhaj EW
    Methods Mol Biol; 2015; 1280():283-95. PubMed ID: 25736755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct, noncatalytic mechanism of IKK inhibition by A20.
    Skaug B; Chen J; Du F; He J; Ma A; Chen ZJ
    Mol Cell; 2011 Nov; 44(4):559-71. PubMed ID: 22099304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A20-mediated negative regulation of canonical NF-κB signaling pathway.
    Pujari R; Hunte R; Khan WN; Shembade N
    Immunol Res; 2013 Dec; 57(1-3):166-71. PubMed ID: 24242761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent inactivation of A20 in B-cell lymphomas.
    Kato M; Sanada M; Kato I; Sato Y; Takita J; Takeuchi K; Niwa A; Chen Y; Nakazaki K; Nomoto J; Asakura Y; Muto S; Tamura A; Iio M; Akatsuka Y; Hayashi Y; Mori H; Igarashi T; Kurokawa M; Chiba S; Mori S; Ishikawa Y; Okamoto K; Tobinai K; Nakagama H; Nakahata T; Yoshino T; Kobayashi Y; Ogawa S
    Nature; 2009 Jun; 459(7247):712-6. PubMed ID: 19412163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis.
    Wang X; Zhu L; Liao Z; Zhang F; Xu L; Xu Y; Chen S; Yang L; Zhou Y; Li Y
    J Immunol Res; 2014; 2014():492872. PubMed ID: 24971370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme.
    Malynn BA; Ma A
    J Exp Med; 2009 May; 206(5):977-80. PubMed ID: 19380636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory disease.
    Zilberman-Rudenko J; Shawver LM; Wessel AW; Luo Y; Pelletier M; Tsai WL; Lee Y; Vonortas S; Cheng L; Ashwell JD; Orange JS; Siegel RM; Hanson EP
    Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1612-7. PubMed ID: 26802121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A20: linking a complex regulator of ubiquitylation to immunity and human disease.
    Ma A; Malynn BA
    Nat Rev Immunol; 2012 Nov; 12(11):774-85. PubMed ID: 23059429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
    Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
    J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deubiquitinases in the regulation of NF-κB signaling.
    Harhaj EW; Dixit VM
    Cell Res; 2011 Jan; 21(1):22-39. PubMed ID: 21119682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An anti-inflammatory role of A20 zinc finger protein during trauma combined with endotoxin challenge.
    Liu B; Jiang D; Ou Y; Hu Z; Jiang J; Lei X
    J Surg Res; 2013 Dec; 185(2):717-25. PubMed ID: 24055365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.